The European Integrated Price Information Database (EURIPID) has been established as voluntary non-profit collaboration of national pricing and reimbursement authorities in European countries. Since its start in 2010, the core intention of the EURIPID Collaboration is to contribute to safeguarding access to affordable medicinal products for all patients and improve transparency in the field of pricing. A total of 26 countries are already members of EURIPID and in regular exchange on pharmaceutical prices. The EURIPID Collaboration has also considered including medical devices into the database and, as part of the grant agreement #826652 EURIPID which is co-funded by the European Union’s Health Programme (2014-2020), agreed to conduct a feasibility study for the integration of medical devices into EURIPID. The study analysed previous work on medical devices within EURIPID, a survey was conducted with the EURIPID collaborating partners to investigate whether or not reimbursement and price lists for medical devices exist in the countries and for which price types. Data for the pricing and reimbursement policy framework of four countries were collected.